Australia Urology Devices Market Overview,2030

The urology devices market in Australia has evolved alongside the country’s highly developed healthcare system and growing demand for advanced surgical and diagnostic technologies to treat urinary tract and kidney-related disorders. Major hospitals such as Royal Prince Alfred Hospital in Sydney, Royal Melbourne Hospital, and Fiona Stanley Hospital in Perth have been early adopters of robotic-assisted and minimally invasive urological procedures. The increasing incidence of urological diseases such as benign prostatic hyperplasia, bladder cancer, and kidney stones—affecting an estimated one in seven Australian men over 50 according to data from the Australian Institute of Health and Welfare—has driven the uptake of next-generation devices like fiber-optic endoscopes, laser lithotripters, and digital cystoscopy systems. Robotics in urology has gained traction with the widespread use of the da Vinci Surgical System and the introduction of modular robotic platforms in teaching hospitals affiliated with Monash University and the University of Queensland. The advancement of flexible endoscopy and the integration of AI-based imaging have enhanced precision in prostate and renal diagnostics. Australia’s growing aged population, with over 16 percent above 65 years, has increased the demand for home-based and portable urological care devices, including smart catheters and sensor-based bladder monitoring systems. Digital transformation initiatives under the Australian Digital Health Agency have supported tele-urology platforms such as TeleHealth Network and Healthdirect, enabling specialists to consult remotely, especially in rural regions of Western Australia and Northern Territory. Local research institutions like CSIRO and the Garvan Institute are exploring 3D printing for patient-specific surgical tools and AI-driven predictive analytics for urinary diseases. Stringent sterilization and reprocessing regulations by the Therapeutic Goods Administration (TGA) ensure adherence to CE and ISO standards, while sustainability goals outlined in the National Waste Policy 2021 promote eco-friendly packaging, single-use device recycling, and environmentally safe disposal practices across Australian healthcare facilities.

According to the research report, ""Australia Urology Devices Market Overview, 2030,"" published by Bonafide Research, the Australia Urology Devices market is anticipated to grow at more than 9.41% CAGR from 2025 to 2030. Australia’s urology devices market is witnessing continuous innovation supported by collaboration between medical institutions, global manufacturers, and local technology startups. Hospitals such as St Vincent’s Health, Westmead Hospital, and Queensland Health have expanded outpatient and day-care urology units, increasing access to non-invasive treatments like laser lithotripsy and cystoscopy for same-day discharge. The adoption of robotic and digital systems has accelerated with installations of da Vinci and Medtronic Hugo robots across multiple hospitals, while laser technology from manufacturers like Lumenis and Boston Scientific has become standard for prostate and kidney stone surgeries. Australian-based company Cook Medical maintains strong manufacturing operations in Brisbane, supplying catheters and stents to hospitals nationwide, while Olympus Australia dominates the flexible endoscopy market through long-standing supply partnerships with public healthcare systems. Strategic collaborations such as the partnership between Stryker and Ramsay Health Care have strengthened robotic surgery training and service networks. The Australian Government supports urological care through Medicare Benefits Schedule reimbursements and kidney disease programs under Kidney Health Australia, which fund diagnostic screenings and dialysis treatment access. Startups like UroPharma and Atomo Diagnostics are developing portable urinary testing devices and mHealth applications for remote monitoring of urinary incontinence and post-surgical recovery. Supply chain management is supported by local distributors such as Device Technologies and Paragon Care, which handle sterile packaging and equipment calibration across state healthcare networks. Universities including the University of New South Wales are conducting R&D on biocompatible materials and nano-coatings to minimize infection risk in reusable urological instruments. Private equity investments from firms like BioScience Managers have been directed toward expanding digital urology platforms and home-use medical technologies. Equipment leasing programs offered by GE Healthcare and Medfin Finance have improved hospital access to high-cost robotic and imaging systems.

In Australia, the urology devices market by type reflects the country’s advanced healthcare infrastructure, high procedural standards, and focus on adopting minimally invasive technologies across public and private medical sectors. The product segment includes diagnostic and surgical instruments such as endoscopes, cystoscopes, ureteroscopes, laser and lithotripsy devices, and dialysis machines that are used extensively in major hospitals like Royal Prince Alfred Hospital in Sydney, Alfred Hospital in Melbourne, and Royal Brisbane and Women’s Hospital. Australian urologists frequently use high-definition endoscopy systems from global manufacturers including Karl Storz, Olympus, and Stryker for bladder, ureter, and kidney procedures. Laser and lithotripsy devices employing Holmium and Thulium fiber laser technologies are deployed for the treatment of urinary stones and prostate enlargement at institutions such as St Vincent’s Hospital in Sydney and Fiona Stanley Hospital in Perth. Extracorporeal shock wave lithotripsy systems are commonly used in regional medical centers for non-invasive kidney stone management. Dialysis devices form a critical part of Australia’s healthcare landscape with machines from Fresenius, Nipro, and Baxter integrated into nephrology-urology departments to support patients with chronic kidney failure. The accessories segment comprises consumables such as Foley catheters, ureteral stents, drainage bags, lubricating gels, and surgical guidewires essential for daily urology operations. Catheters from companies like Coloplast, Teleflex, and B. Braun are standard across Australian hospitals and community health services. Lubricants and hydrophilic gels are routinely used in urological examinations to reduce discomfort and tissue damage during catheterization and endoscopy. Strict infection control protocols enforced by the Therapeutic Goods Administration have driven hospitals to adopt single-use devices and sterile accessories. The durable capital equipment and precision-engineered consumables underscores Australia’s commitment to safety, innovation, and quality in the field of urological device utilization nationwide.

In Australia, urology devices are used across a wide range of clinical applications that reflect the country’s high healthcare standards and growing focus on preventive and minimally invasive treatments. Urolithiasis (stone disease) is one of the most prevalent urological conditions in the country, particularly in regions with hotter climates such as Queensland and Western Australia where dehydration contributes to kidney stone formation. Hospitals like the Royal Melbourne Hospital and Gold Coast University Hospital use flexible ureteroscopes, nephroscopes, and laser lithotripters to manage stone disease with minimally invasive techniques. Benign Prostatic Hyperplasia (BPH) is treated using laser vaporization and water vapor therapy devices in medical centers such as the Austin Hospital in Melbourne and Royal North Shore Hospital in Sydney. Urological cancers, including prostate, bladder, and kidney cancers, are managed through robotic-assisted surgical systems like the da Vinci Surgical System, widely adopted in cancer treatment centers such as Chris O’Brien Lifehouse and Peter MacCallum Cancer Centre. Urinary incontinence and pelvic organ prolapse treatments are commonly performed in women’s health clinics across Brisbane and Adelaide, using sling procedures, bulking agents, and artificial urinary sphincters to restore continence. Erectile dysfunction care includes penile implants, vacuum erection systems, and pharmacological adjuncts provided in men’s health centers throughout Perth and Hobart. Kidney diseases requiring dialysis are treated in nephrology-urology units across public hospitals and specialized centers managed by Fresenius Medical Care and Diaverum. Other applications, such as pediatric urology, congenital anomalies, and strictures, are addressed at children’s hospitals like The Royal Children’s Hospital in Melbourne, using small-diameter cystoscopes and catheters. Across Australia, the integration of laser systems, imaging technologies, and robotic platforms highlights the country’s emphasis on clinical precision, shorter hospital stays, and enhanced patient recovery outcomes in urological practice.

In Australia, urology devices are widely used across hospitals, clinics, dialysis centers, and home care settings, reflecting the country’s comprehensive and technologically advanced healthcare delivery system. Hospitals and clinics represent the primary end users, with leading institutions such as Royal Prince Alfred Hospital in Sydney, Fiona Stanley Hospital in Perth, and The Alfred Hospital in Melbourne equipped with state-of-the-art endoscopic suites, laser lithotripters, and robotic-assisted surgical systems for treating complex urological conditions. These facilities provide a wide range of services including stone management, prostate surgeries, and bladder cancer resections. Private hospital networks such as Ramsay Health Care and Healthscope operate specialized urology departments offering minimally invasive outpatient procedures using portable lithotripsy and laser systems. Regional and teaching hospitals collaborate with the Urological Society of Australia and New Zealand to train surgeons in advanced robotic and laparoscopic techniques. Dialysis centers play a vital role in supporting patients with chronic kidney disease and associated urinary complications. Facilities managed by Fresenius, Diaverum, and Baxter provide hemodialysis and peritoneal dialysis across major cities and rural areas, often integrated with hospital-based nephrology-urology units for multidisciplinary care. These centers maintain strict safety and monitoring standards to ensure continuity of treatment. Home care settings have grown significantly as part of Australia’s healthcare model promoting patient autonomy and remote management. Patients use intermittent self-catheterization kits, portable drainage systems, and home dialysis devices supplied by companies such as B. Braun and Coloplast, supported by home-nursing services and telehealth platforms. Government-funded programs under Medicare provide financial support for home-based chronic care equipment. The strong coordination between hospitals, dialysis providers, and home healthcare networks demonstrates Australia’s commitment to accessibility, quality, and technological excellence in managing urological and renal health conditions across the population.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Urology Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Product
• Accessories

By Application
• Urolithiasis (Stone Disease)
• Benign Prostatic Hyperplasia (BPH)
• Urological Cancers
• Urinary Incontinence & Pelvic Organ Prolapse
• Erectile Dysfunction
• Kidney Diseases
• Other Applications (Pediatrics, Strictures, Infections, etc.)

By End Use
• Hospitals and clinics
• Dialysis centers
• Others (Home care settings) Show more